A Comprehensive Review on Weight Gain Following Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists for Obesity
CrossRef Mechanism of Huanglian Wendan Decoction in ameliorating non-alcoholic fatty liver disease via modulating gut microbiota-mediated metabolic reprogramming and activating the LKB1/AMPK pathway Jianping Zhu, Yuzhen Chen, Yidi Han, Ji Li, Fahrul Nurkolis PLOS One .2025
Your health journey is uniquely yours, and Im here to help you navigate it with all the care and support possible
If you have a true history of severe or active pancreatitis, retatrutide is not recommended
All the treatments under Dr
And on the horizon, with an FDA decision expected by April 10, 2026, is orforglipron, Eli Lilly's next-generation oral GLP-1 that could reshape the entire landscape of medically assisted weight management